Skip to main content

Akinsanya Karen

In the past year, 3 open-market sale filings worth $972.0K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$972.0K
3 filings
Net
−$972.0K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Akinsanya Karen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

SDGR Schrodinger, Inc.

See Remarks7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 17, 2021 (view filing)Aug 161 dayAkinsanya KarenSee RemarksSSale−37.7K$57.74−$2.18M−100.0%0 after2 lots
Sep 16, 2021 (view filing)Sep 151 dayAkinsanya KarenSee RemarksSSale−1.39K$61.13−$85.2K−100.0%0 after
Oct 19, 2021 (view filing)Oct 154 daysAkinsanya KarenSee RemarksSSale−1.39K$55.75−$77.7K−100.0%0 after
Apr 15, 2025 (view filing)Apr 141 dayAkinsanya KarenPresident of R&D, TherapeuticsSSale−16.7K$25.09−$419.5K−51.7%15.6K after3 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayAkinsanya KarenSee RemarksSSale−2.21K$11.99−$26.4K−3.0%71.3K after10b5-1
Mar 6, 2026 (view filing)Mar 51 dayAkinsanya KarenSee RemarksSSale−1.37K$12.90−$17.6K−1.9%70.0K after10b5-1
Sep 21, 2026 (view filing)5:15 PM ETSep 174 daysAkinsanya KarenSee RemarksSSale−31.6K$29.37−$928.0K−31.1%70.0K after2 lots10b5-1